Evidence map›Paper›PMID 34511869›Full record

ArticleClinical ophthalmology (Auckland, N.Z.)2021

Ellipsoid Spectacle Comparison of Plusoptix, Retinomax and 2WIN Autorefractors.

Robert W Arnold, Samuel J Martin, Joshua R Beveridge, Andrew W Arnold, Stephanie L Arnold, Nathanael R Beveridge, Kyle A Smith

Open access · goldAbstract read
In one paragraph

Article in Clinical ophthalmology (Auckland, N.Z.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Deep learning-empowered low-cost portable automated refraction system: A solution to the inadequate effective correction rate of refractive errors in resource-limited areas.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2025
    Trial
  2. Article
  3. Article
  4. Article
  5. Multifaceted Amblyopia Screening with blinq, 2WIN, and PDI Check.Clinical ophthalmology (Auckland, N.Z.) · 2022
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Robert W ArnoldAlaska Blind Child Discovery, Alaska Children's EYE & Strabismus, Anchorage, AK, 99508, USA.ORCID 0000-0002-5061-7717
Samuel J MartinLoma Linda Medical School, Loma Linda, CA, USA.
Joshua R BeveridgeIdaho College of Osteopathic Medicine, Boise, ID, USA.
Andrew W ArnoldAscension Genesys Residency Program, Grand Blanc, MI, USA.
Stephanie L ArnoldAscension Genesys Residency Program, Grand Blanc, MI, USA.
Nathanael R BeveridgeUS Airforce Academy, Colorado Springs, CO, USA.
Kyle A SmithAlaska Blind Child Discovery, Alaska Children's EYE & Strabismus, Anchorage, AK, 99508, USA.ORCID 0000-0002-6220-4856
Genesys (United States) · USLoma Linda University Medical Center · USUnited States Air Force Academy · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHandheld devices can automatically give an estimate of refraction. The established method for refraction comparison using spherical equivalent (M) and J0, J45 vector transformations by Bland-Altman analysis is too complex for non-eye doctors involved with vision screening and remote vision clinics. Therefore, a simpler comparison technique was developed.

methodsBased on the spectacle limit to resolve grade A 1 logMAR, B 3 logMAR and C 6 logMAR blur, J0, J45, and M are combined into the Alaska Blind Child Discovery (ABCD) composite ellipsoid GRADE system. Pediatric eye patients had confirmatory examination after dry refraction with three portable autorefractors: Plusoptix, 2WIN and Retinomax. The refractions were then compared using both Bland-Altman and ABCD composite. Performance to detect AAPOS amblyopia risk factors was also assessed.

resultsA total of 202 children, mean age seven years, 28% high spectacle need and 43% AAPOS 2013 amblyopia risk factors showed high correlation with cycloplegic refraction (intraclass correlation 0.49 to 0.90) for sphere, J0 and J45 spectacle components. Plusoptix had more (10%) inconclusives due to patients out-of-range. The Retinomax was unable to screen some younger children and was less reliable for sphere but gave more precise astigmatism estimates. The proportion of autorefractions expected to give GRADE A/B high-need patients acuity improvement to 20/40 would be 41% for Plusoptix, 39% for 2WIN and 65% for Retinomax. Sensitivity/specificity for amblyopia risk factor detection was 80%/83% for Plusoptix, 72%/88% for 2WIN and 84%/73% for Retinomax.

conclusionThe simplified spectacle comparison resembled Bland-Altman and could assist lay vision screeners and non-eye doctors attempting remote spectacle donation worldwide.

Indexed as

autorefractorsremote dispensingspectaclesvalidation

Identifiers

PMID34511869
PMCPMC8415895
OpenAlexW3196531122

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.